Washington, Oct 19 (EFE).- The United States on Wednesday approved the use of Novavax’s Covid-19 vaccine as a booster for adults. Novavax thus joins Pfizer-BioNTech and Moderna, which already have the US Food and Drug Administration approval for booster doses. The FDA granted Novavax emergency authorization, and the Centers for Disease Control and Prevention (CDC) …